Risk of Osteoarthritis and Arthroplasty Between Baclofen and Tizanidine: A Target Trial Emulation Study.
- Published in:
- Clinical Drug Investigation, 2025, v. 45, n. 6, p. 335, doi. 10.1007/s40261-025-01448-5
- By:
- Publication type:
- Article
Works matching IS 11732563 AND DT 2025 AND VI 45 AND IP 6
Results: 6
1
2
Risk of Ophthalmotoxicity Associated with Antibody-Drug Conjugates: A Systematic Review and Meta-analysis.
- Published in:
- Clinical Drug Investigation, 2025, v. 45, n. 6, p. 295, doi. 10.1007/s40261-025-01447-6
- By:
- Publication type:
- Article
3
Cost-Effectiveness Analysis of Pembrolizumab Plus Chemotherapy Compared with Chemotherapy as First-Line Treatment for Advanced PD-L1-Positive Triple-Negative Breast Cancer from a Japanese Healthcare Perspective.
- Published in:
- Clinical Drug Investigation, 2025, v. 45, n. 6, p. 317, doi. 10.1007/s40261-025-01445-8
- By:
- Publication type:
- Article
4
Super Responder Profile Under Bimekizumab Treatment in Moderate-to-Severe Psoriasis: A Short Term Real-Life Observation—IL PSO (Italian Landscape Psoriasis).
- Published in:
- Clinical Drug Investigation, 2025, v. 45, n. 6, p. 309, doi. 10.1007/s40261-025-01440-z
- By:
- Publication type:
- Article
5
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Axatilimab in Healthy Japanese Male Participants: Results from a Phase 1, Randomized, Double-Blind, Dose-Escalation Study.
- Published in:
- Clinical Drug Investigation, 2025, v. 45, n. 6, p. 327, doi. 10.1007/s40261-025-01438-7
- By:
- Publication type:
- Article
6
Cost-Effectiveness Analysis of Nirsevimab for the Prevention of Respiratory Syncytial Virus among Italian Infants.
- Published in:
- Clinical Drug Investigation, 2025, v. 45, n. 6, p. 347, doi. 10.1007/s40261-025-01437-8
- By:
- Publication type:
- Article